Dynavax Says Covid-19 Vaccine Trial Could Start as Soon as July

Dynavax Technologies sees one or more of its collaboration partners commence a Phase 1 clinical trial of a potential COVID-19 vaccine as soon as July 2020.

• Co. to provide an update on its early-stage collaborations regarding the potential development of a vaccine for COVID-19 on May 19
• Co. shares up about 20% post-market

To view the source of this information click here

To contact the reporter on this story:
Cara Moffat in Los Angeles at cmoffat@bloomberg.net

To contact the editor responsible for this story:
Lauren Berry at lberry4@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.